OCULAR THERAPEUTIX INC
For the period ended Dec 31, 2023. Filed Mar 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 11, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
| Item 15. | Exhibits, Financial Statement Schedules |
|---|
The following financial statements are filed as part of this Annual Report on Form 10-K:
| | ||
|---|---|---|
| | Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | | F-2 |
| Consolidated Balance Sheets | | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss | | F-5 |
| Consolidated Statements of Changes in Stockholders’ Equity (Deficit) | | F-6 |
| Consolidated Statements of Cash Flows | | F-7 |
| Notes to Consolidated Financial Statements | | F-8 |
No financial statement schedules have been filed as part of this Annual Report on Form 10-K because they are not applicable, not required or because the information is otherwise included in our consolidated financial statements or notes thereto.
The exhibits filed as part of this Annual Report on Form 10-K are set forth on the Exhibit Index immediately following Item 16. The Exhibit Index is incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.